GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -5,560 | -1,480 | -330 | -190 |
| Depreciation Amortization | 550 | 50 | 40 | 20 |
| Other Operating Activity | 5,390 | -140 | -240 | -50 |
| Operating Cash Flow | $380 | $-1,570 | $-530 | $-220 |
| Cash Flows From Investing Activities | ||||
| Other Investing Activity | -220 | 2,020 | 510 | -130 |
| Investing Cash Flow | $-220 | $2,020 | $510 | $-130 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 20 | 0 | 0 | 0 |
| Financing Cash Flow | $20 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 750 | 300 | 330 | 690 |
| End Cash Position | 930 | 750 | 300 | 330 |
| Net Cash Flow | $170 | $450 | $-20 | $-360 |
| Free Cash Flow | ||||
| Operating Cash Flow | 380 | -1,570 | -530 | -220 |
| Free Cash Flow | 380 | -1,570 | -530 | -220 |